Injective (INJ) Price Up 5.8% in 24 Hours

Injective (INJ), the native token of the Injective blockchain, recorded a 5.78% gain against the US dollar over the past 24 hours, reaching $4.8586 at the time of reporting. The move came alongside a sharp increase in trading activity, with $92.2 million worth of INJ changing hands across 583 separate markets.

That level of volume represents a notable pickup in liquidity, suggesting that the price move was supported by active buying and selling rather than thin order books. The token’s total supply is capped at 100 million, with nearly all of that — 99,970,954.5 INJ — already in circulation.

No single catalyst for the jump was immediately apparent. Like many altcoins, INJ often moves in sympathy with broader crypto sentiment and sector-specific news around decentralized finance (DeFi), where Injective positions itself as a layer‑1 blockchain built for financial applications.

Trading Context and Supply Snapshot

Injective’s Supply and Market Structure

The token’s fully diluted float — with essentially the entire 100‑million supply in circulation — means that no future unlocks will dilute existing holders. This is a structural feature that can attract traders who are wary of scheduled token dumps. The high volume‑to‑price ratio seen in the past 24 hours also indicates that the market for INJ is reasonably liquid, allowing participants to enter and exit positions without excessive slippage.

Liquidity and What the Numbers Mean

A trading volume of $92.2 million relative to a $4.86 price implies a turnover of roughly 19 million tokens in a day, or about 19% of the circulating supply. Ratios above 15-20% over 24 hours are often interpreted as signs of heightened speculative interest. Without identifying a specific driver — no protocol upgrade, partnership, or exchange listing was flagged — the most likely explanation is that INJ caught a bid in a risk‑on session across broader crypto markets.